Showing 1491-1500 of 1697 results for "".
- Phase 3 Study of Tolperisone for Muscle Spasms Completes Enrollmenthttps://practicalneurology.com/news/phase-3-study-of-tolperisone-for-muscle-spasms-completes-enrollment/2469759/Enrollment of 1,000 participants is complete for the phase 3 RESUME-1 study (NCT04671082) of tolperisone (Mydocalm; Neurana Pharmaceuticals, San Diego, CA) for muscle spasms associated with acute,
- Ganaxolone Reduces Seizure Frequency in Tuberous Sclerosis Complexhttps://practicalneurology.com/news/ganaxolone-reduces-seizure-frequency-in-tuberous-sclerosis-complex/2469673/In an open-label phase 2 trial (NCT04285346), ganaxolone (Marinus Pharmaceuticals, Radnor, PA) treatment of 23 participants with seizures associated with tuberous sclerosis complex (TSC) reduced s
- FDA Approves Implanted Spinal Cord Stimulator for Chronic Painful Diabetic Neuropathyhttps://practicalneurology.com/news/fda-approves-implanted-spinal-cord-stimulator-for-chronic-painful-diabetic-neuropathy/2469638/The Food and Drug Administration (FDA) granted premarket approval to an implanted spinal cord stimulator (Senza System; Nevro, Redwood City, CA) for treatment of chronic pain associated with painful diabetic neuropathy (PDN). As published in
- Pursuit of Alzheimer Disease Treatments Relying Heavily on Publicly and Academically Funded Research as Pharma Steps Backhttps://practicalneurology.com/news/pursuit-of-alzheimer-disease-treatments-relying-heavily-on-publicly-and-academically-funded-research-as-pharma-steps-back/2469598/The journal Alzheimer's & Dementia: Translational Research & Clinical Interventions and Studies, published by the Alzheimer's Association, has published 2 studies showing a shift in how rese
- Risk of In-Hospital Stroke Higher Among Those With COVID-19https://practicalneurology.com/news/risk-of-in-hospital-stroke-higher-among-those-with-covid-19/2469530/A study presented at the American Stroke Association’s virtual International Stroke Conference 2021 showed individuals hospitalized with COVID-19 had a higher risk of stroke compared to those who were h
- Plasmapheresis With Albumin Delays Cognitive and Functional Declines in Clinical Trial for Alzheimer Diseasehttps://practicalneurology.com/news/plasmapheresis-with-albumin-delays-cognitive-and-functional-declines-in-clinical-trial-for-alzheimer-disease/2469334/The Journal of the Alzheimer's and Dementia Association, the peer-reviewed scientific journal, today has published Results from the Alzheimer's disease Management by Albumin Replacement (AMBAR) study (
- Chronic Stress of Discrimination Increases Hypertension Risk in African Americanshttps://practicalneurology.com/news/chronic-stress-of-discrimination-increases-hypertension-risk-in-african-americans/2469311/Lifetime discrimination is a chronic stressor that may increase the risk for hypertension in African Americans, according to new research published today in Hypertension, an American Heart Association journal. <
- MDA Provides COVID-19 Recommendations for People with Neuromuscular Conditions that Also Apply to Other Neurologic Conditionshttps://practicalneurology.com/news/mda-provides-covid-19-recommendations-for-people-with-neuromuscular-conditions-that-also-apply-to-other-neurologic-conditions/2469188/The Muscular Dystrophy Association (MDA) has provided recommendations for people in the neuromuscular community regarding the current COVID-19 pandemic. Noting that current guidelines from public health agencies focus on travelers, specific age group
- Newly Identified Gene Variants May Increase Susceptibility to Tauopathieshttps://practicalneurology.com/news/newly-identified-gene-variants-may-increase-susceptibility-to-tauopathies/2469181/In a preliminary study released today, researchers identified gene variants that are associated with a susceptibility to developing tau deposits with age. It is known that the protein tau develops into tangles in the brains of people with Alzheimer disease (AD), but understand of factors that cau
- Cannabidiol Reduces Seizures in People With Tuberous Sclerosis Complex-Related Seizures in Clinical Trialshttps://practicalneurology.com/news/cannabidiol-reduces-seizures-in-people-with-tuberous-sclerosis-complex-related-seizures-in-clinical-trials/2469097/Findings from a clinical trial (NCT02544763) presented at the American Epilepsy Society Annual Meeting December 6-10, 2019 in Baltimore, MD showed that people with tuberous sclerosis complex (TSC), a genetic condition associated with t